Related references
Note: Only part of the references are listed.From benzalkonium chloride-preserved Latanoprost to Polyquad-preserved Travoprost: a 6-month study on ocular surface safety and tolerability
Gemma Caterina Maria Rossi et al.
EXPERT OPINION ON DRUG SAFETY (2015)
Comparative Efficacy and Tolerability of Topical Prostaglandin Analogues for Primary Open-Angle Glaucoma and Ocular Hypertension
Liang Lin et al.
ANNALS OF PHARMACOTHERAPY (2014)
Randomized Clinical Trial of the Efficacy and Safety of Preservative-free Tafluprost and Timolol in Patients With Open-Angle Glaucoma or Ocular Hypertension
Almira Chabi et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2012)
A Prospective Study Evaluating IOP Changes after Switching from a Therapy with Prostaglandin Eye Drops Containing Preservatives to Nonpreserved Tafluprost in Glaucoma Patients
Stefano Ranno et al.
SCIENTIFIC WORLD JOURNAL (2012)
Switching patients from preserved prostaglandin-analog monotherapy to preservative-free tafluprost
Anton Hommer et al.
CLINICAL OPHTHALMOLOGY (2011)
Mixed treatment comparison and meta-regression of the efficacy and safety of prostaglandin analogues and comparators for primary open-angle glaucoma and ocular hypertension
M. Orme et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Preservatives in eye drops: Toward awareness of their toxicity
D. Vaede et al.
JOURNAL FRANCAIS D OPHTALMOLOGIE (2010)
Diurnal IOP-lowering efficacy and safety of travoprost 0.004% compared with tafluprost 0.0015% in patients with primary open-angle glaucoma or ocular hypertension
Dietmar Schnober et al.
CLINICAL OPHTHALMOLOGY (2010)
Quantitative analysis of conjunctival goblet cells after chronic application of topical drops
Malik Y. Kahook et al.
ADVANCES IN THERAPY (2008)
Conjunctival and corneal reactions in rabbits following short- and repeated exposure to preservative-free tafluprost, commercially available latanoprost and 0.02% benzalkonium chloride
H. Liang et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Meta-analysis of 13 randomized controlled trials comparing bimatoprost with latanoprost in patients with elevated intraocular pressure
Jin-Wei Cheng et al.
CLINICAL THERAPEUTICS (2008)
In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line
Emmanuelle Brasnu et al.
CURRENT EYE RESEARCH (2008)
Efficacy and Tolerability of Prostaglandin Analogs A Meta-analysis of Randomized Controlled Clinical Trials
Florent Aptel et al.
JOURNAL OF GLAUCOMA (2008)
A comparative study of bimatoprost and travoprost: Effect on intraocular pressure and ocular circulation in newly diagnosed glaucoma patients
Gursoy Alagoz et al.
OPHTHALMOLOGICA (2008)
A meta-analysis of topical prostaglandin analogues intraocular pressure lowering in glaucoma therapy
Ph. Denise et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Travoprost compared with other prostaglandin analogues or timolol in patients with open-angle glaucoma or ocular hypertension: meta-analysis of randomized controlled trials
Ni Li et al.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2006)
The number of people with glaucoma worldwide in 2010 and 2020
HA Quigley et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2006)
Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension
N Orzalesi et al.
OPHTHALMOLOGY (2006)
Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma
S Holmstrom et al.
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Herpes simplex virus genome quantification in two patients who developed herpetic epithelial keratitis during treatment with antiglaucoma medications
T Deai et al.
CORNEA (2004)
A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension
SM Whitcup et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2003)
Comparison of travoprost 0.0015% and 0.004% with timolol 0.5% in patients with elevated intraocular pressure - A 6-month, masked, multicenter trial
RL Fellman et al.
OPHTHALMOLOGY (2002)
Share Paper
